Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Videm

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Perfusion|December 24, 2010
Biocompatibility and pathways of initial complement pathway activation with Phisio- and PMEA-coated cardiopulmonary bypass circuits during open-heart surgeryA S Thiara, T E Mollnes, V Videm, et al.
Perfusion|February 23, 2010
Comparable biocompatibility of Phisio- and Bioline-coated cardiopulmonary bypass circuits indicated by the inflammatory responseA S Thiara, V Y Andersen, V Videm, et al.
Internal Medicine Journal|September 19, 2015
Safety and retention of combination triple disease-modifying anti-rheumatic drugs in new-onset rheumatoid arthritisL Cummins, V S Katikireddi, S Shankaranarayana, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 30, 1999
Heparin-coated cardiopulmonary bypass equipment. I. Biocompatibility markers and development of complications in a high-risk populationV Videm, T E Mollnes, E Fosse, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 30, 1999
Heparin-coated cardiopulmonary bypass equipment. II. Mechanisms for reduced complement activation in vivoV Videm, T E Mollnes, K Bergh, et al.
Perfusion|March 13, 1999
In vitro evaluation of new surface coatings for extracorporeal circulationS T Baksaas, V Videm, E Fosse, et al.
Scandinavian Journal of Immunology|July 4, 1998
Immunoglobulin prolongs survival of pig kidneys perfused ex vivo with human bloodA E Fiane, V Videm, O J Mellbye, et al.
Transplantation Proceedings|December 1, 1995
Ex vivo model for xenotransplantationA E Fiane, V Videm, T Scholz, et al.
Xenotransplantation|October 3, 1999
Compstatin, a peptide inhibitor of C3, prolongs survival of ex vivo perfused pig xenograftsA E Fiane, T E Mollnes, V Videm, et al.
Transplantation Proceedings|March 20, 1999
Prolongation of ex vivo-perfused pig xenograft survival by the complement inhibitor CompstatinA E Fiane, T E Mollnes, V Videm, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Perfusion|December 24, 2010
Biocompatibility and pathways of initial complement pathway activation with Phisio- and PMEA-coated cardiopulmonary bypass circuits during open-heart surgeryA S Thiara, T E Mollnes, V Videm, et al.
Perfusion|February 23, 2010
Comparable biocompatibility of Phisio- and Bioline-coated cardiopulmonary bypass circuits indicated by the inflammatory responseA S Thiara, V Y Andersen, V Videm, et al.
Internal Medicine Journal|September 19, 2015
Safety and retention of combination triple disease-modifying anti-rheumatic drugs in new-onset rheumatoid arthritisL Cummins, V S Katikireddi, S Shankaranarayana, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 30, 1999
Heparin-coated cardiopulmonary bypass equipment. I. Biocompatibility markers and development of complications in a high-risk populationV Videm, T E Mollnes, E Fosse, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 30, 1999
Heparin-coated cardiopulmonary bypass equipment. II. Mechanisms for reduced complement activation in vivoV Videm, T E Mollnes, K Bergh, et al.
Perfusion|March 13, 1999
In vitro evaluation of new surface coatings for extracorporeal circulationS T Baksaas, V Videm, E Fosse, et al.
Scandinavian Journal of Immunology|July 4, 1998
Immunoglobulin prolongs survival of pig kidneys perfused ex vivo with human bloodA E Fiane, V Videm, O J Mellbye, et al.
Transplantation Proceedings|December 1, 1995
Ex vivo model for xenotransplantationA E Fiane, V Videm, T Scholz, et al.
Xenotransplantation|October 3, 1999
Compstatin, a peptide inhibitor of C3, prolongs survival of ex vivo perfused pig xenograftsA E Fiane, T E Mollnes, V Videm, et al.
Transplantation Proceedings|March 20, 1999
Prolongation of ex vivo-perfused pig xenograft survival by the complement inhibitor CompstatinA E Fiane, T E Mollnes, V Videm, et al.
Pageof 7